Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 122

1.

ATAD2 is associated with malignant characteristics of pancreatic cancer cells.

Liu N, Funasaka K, Obayashi T, Miyahara R, Hirooka Y, Goto H, Senga T.

Oncol Lett. 2019 Mar;17(3):3489-3494. doi: 10.3892/ol.2019.9960. Epub 2019 Jan 23.

2.

PAI-1 secreted from metastatic ovarian cancer cells triggers the tumor-promoting role of the mesothelium in a feedback loop to accelerate peritoneal dissemination.

Peng Y, Kajiyama H, Yuan H, Nakamura K, Yoshihara M, Yokoi A, Fujikake K, Yasui H, Yoshikawa N, Suzuki S, Senga T, Shibata K, Kikkawa F.

Cancer Lett. 2019 Feb 1;442:181-192. doi: 10.1016/j.canlet.2018.10.027. Epub 2018 Oct 26.

PMID:
30429105
3.

The role of E2F8 in the human placenta.

Mizuno M, Miki R, Moriyama Y, Ushida T, Imai K, Niimi K, Nakano T, Tsuda H, Sumigama S, Yamamoto E, Senga T, Iwase A, Kikkawa F, Kotani T.

Mol Med Rep. 2019 Jan;19(1):293-301. doi: 10.3892/mmr.2018.9617. Epub 2018 Nov 1.

4.

Hematopoietic lineage cell-specific protein 1 (HS1), a hidden player in migration, invasion, and tumor formation, is over-expressed in ovarian carcinoma cells.

Koya Y, Liu W, Yamakita Y, Senga T, Shibata K, Yamashita M, Nawa A, Kikkawa F, Kajiyama H.

Oncotarget. 2018 Aug 24;9(66):32609-32623. doi: 10.18632/oncotarget.25975. eCollection 2018 Aug 24.

5.

FAM98A is localized to stress granules and associates with multiple stress granule-localized proteins.

Ozeki K, Sugiyama M, Akter KA, Nishiwaki K, Asano-Inami E, Senga T.

Mol Cell Biochem. 2019 Jan;451(1-2):107-115. doi: 10.1007/s11010-018-3397-6. Epub 2018 Jul 10.

PMID:
29992460
6.

Hematopoietic lineage cell-specific protein 1 immunoreactivity indicates an increased risk of poor overall survival in patients with ovarian carcinoma.

Liu W, Kajiyama H, Shibata K, Koya Y, Senga T, Kikkawa F.

Oncol Lett. 2018 Jun;15(6):9406-9412. doi: 10.3892/ol.2018.8493. Epub 2018 Apr 13.

7.

KIF20A expression as a prognostic indicator and its possible involvement in the proliferation of ovarian clear‑cell carcinoma cells.

Kawai Y, Shibata K, Sakata J, Suzuki S, Utsumi F, Niimi K, Sekiya R, Senga T, Kikkawa F, Kajiyama H.

Oncol Rep. 2018 Jul;40(1):195-205. doi: 10.3892/or.2018.6401. Epub 2018 Apr 25.

8.

Inhibition of ZEB1 leads to inversion of metastatic characteristics and restoration of paclitaxel sensitivity of chronic chemoresistant ovarian carcinoma cells.

Sakata J, Utsumi F, Suzuki S, Niimi K, Yamamoto E, Shibata K, Senga T, Kikkawa F, Kajiyama H.

Oncotarget. 2017 Aug 10;8(59):99482-99494. doi: 10.18632/oncotarget.20107. eCollection 2017 Nov 21.

9.

A novel mechanism of neovascularization in peritoneal dissemination via cancer-associated mesothelial cells affected by TGF-β derived from ovarian cancer.

Fujikake K, Kajiyama H, Yoshihara M, Nishino K, Yoshikawa N, Utsumi F, Suzuki S, Niimi K, Sakata J, Mitsui H, Shibata K, Senga T, Kikkawa F.

Oncol Rep. 2018 Jan;39(1):193-200. doi: 10.3892/or.2017.6104. Epub 2017 Nov 20.

PMID:
29192324
10.

Impact of positive ZEB1 expression in patients with epithelial ovarian carcinoma as an oncologic outcome-predicting indicator.

Sakata J, Kajiyama H, Suzuki S, Utsumi F, Niimi K, Sekiya R, Shibata K, Senga T, Kikkawa F.

Oncol Lett. 2017 Oct;14(4):4287-4293. doi: 10.3892/ol.2017.6658. Epub 2017 Jul 24.

11.

Dynamic plasticity in phototransduction regulates seasonal changes in color perception.

Shimmura T, Nakayama T, Shinomiya A, Fukamachi S, Yasugi M, Watanabe E, Shimo T, Senga T, Nishimura T, Tanaka M, Kamei Y, Naruse K, Yoshimura T.

Nat Commun. 2017 Sep 4;8(1):412. doi: 10.1038/s41467-017-00432-8.

12.

Phosphorylation of DEPDC1 at Ser110 is required to maintain centrosome organization during mitosis.

Chen D, Ito S, Hyodo T, Asano-Inami E, Yuan H, Senga T.

Exp Cell Res. 2017 Sep 15;358(2):101-110. doi: 10.1016/j.yexcr.2017.06.005. Epub 2017 Jun 9.

PMID:
28602627
13.

Demonstration of electron beam laser excitation in the UV range using a GaN/AlGaN multiquantum well active layer.

Hayashi T, Kawase Y, Nagata N, Senga T, Iwayama S, Iwaya M, Takeuchi T, Kamiyama S, Akasaki I, Matsumoto T.

Sci Rep. 2017 Jun 7;7(1):2944. doi: 10.1038/s41598-017-03151-8.

14.

HOXD8 exerts a tumor-suppressing role in colorectal cancer as an apoptotic inducer.

Mansour MA, Senga T.

Int J Biochem Cell Biol. 2017 Jul;88:1-13. doi: 10.1016/j.biocel.2017.04.011. Epub 2017 Apr 27.

PMID:
28457970
15.

AMPD3 is associated with the malignant characteristics of gastrointestinal stromal tumors.

Wong M, Funasaka K, Obayashi T, Miyahara R, Hirooka Y, Hamaguchi M, Goto H, Senga T.

Oncol Lett. 2017 Mar;13(3):1281-1287. doi: 10.3892/ol.2016.5532. Epub 2016 Dec 23.

16.

Interleukin-1β activates focal adhesion kinase and Src to induce matrix metalloproteinase-9 production and invasion of MCF-7 breast cancer cells.

Mon NN, Senga T, Ito S.

Oncol Lett. 2017 Feb;13(2):955-960. doi: 10.3892/ol.2016.5521. Epub 2016 Dec 20.

17.

Role of Caveolin-1 for Blocking the Epithelial-Mesenchymal Transition in Proliferative Vitreoretinopathy.

Nagasaka Y, Kaneko H, Ye F, Kachi S, Asami T, Kato S, Takayama K, Hwang SJ, Kataoka K, Shimizu H, Iwase T, Funahashi Y, Higuchi A, Senga T, Terasaki H.

Invest Ophthalmol Vis Sci. 2017 Jan 1;58(1):221-229. doi: 10.1167/iovs.16-20513.

PMID:
28114583
18.

TRIP13 is expressed in colorectal cancer and promotes cancer cell invasion.

Kurita K, Maeda M, Mansour MA, Kokuryo T, Uehara K, Yokoyama Y, Nagino M, Hamaguchi M, Senga T.

Oncol Lett. 2016 Dec;12(6):5240-5246. doi: 10.3892/ol.2016.5332. Epub 2016 Nov 1.

19.

Murine Experimental Model of Original Tumor Development and Peritoneal Metastasis via Orthotopic Inoculation with Ovarian Carcinoma Cells.

Koya Y, Kajiyama H, Liu W, Shibata K, Senga T, Kikkawa F.

J Vis Exp. 2016 Dec 9;(118). doi: 10.3791/54353.

20.

FAM98A associates with DDX1-C14orf166-FAM98B in a novel complex involved in colorectal cancer progression.

Akter KA, Mansour MA, Hyodo T, Senga T.

Int J Biochem Cell Biol. 2017 Mar;84:1-13. doi: 10.1016/j.biocel.2016.12.013. Epub 2016 Dec 28.

PMID:
28040436
21.

An immuno-wall microdevice exhibits rapid and sensitive detection of IDH1-R132H mutation specific to grade II and III gliomas.

Yamamichi A, Kasama T, Ohka F, Suzuki H, Kato A, Motomura K, Hirano M, Ranjit M, Chalise L, Kurimoto M, Kondo G, Aoki K, Kaji N, Tokeshi M, Matsubara T, Senga T, Kaneko MK, Suzuki H, Hara M, Wakabayashi T, Baba Y, Kato Y, Natsume A.

Sci Technol Adv Mater. 2016 Oct 4;17(1):618-625. eCollection 2016.

22.

A regulatory subunit of protein phosphatase 2A, PPP2R5E, regulates the abundance of microtubule crosslinking factor 1.

Hyodo T, Ito S, Asano-Inami E, Chen D, Senga T.

FEBS J. 2016 Oct;283(19):3662-3671. doi: 10.1111/febs.13835.

23.

Nek2 siRNA therapy using a portal venous port-catheter system for liver metastasis in pancreatic cancer.

Kokuryo T, Hibino S, Suzuki K, Watanabe K, Yokoyama Y, Nagino M, Senga T, Hamaguchi M.

Cancer Sci. 2016 Sep;107(9):1315-20. doi: 10.1111/cas.12993. Epub 2016 Aug 12.

24.

α-Bisabolol Inhibits Invasiveness and Motility in Pancreatic Cancer Through KISS1R Activation.

Uno M, Kokuryo T, Yokoyama Y, Senga T, Nagino M.

Anticancer Res. 2016 Feb;36(2):583-9.

PMID:
26851012
25.

Erratum to: FAM98A is a novel substrate of PRMT1 required for tumor cell migration, invasion and colony formation.

Akter KA, Mansour MA, Hyodo T, Ito S, Hamaguchi M, Senga T.

Tumour Biol. 2016 May;37(5):7001. No abstract available.

PMID:
26825979
26.

Erratum to: UBE2S is associated with malignant characteristics of breast cancer cells.

Akter KA, Hyodo T, Asano E, Sato N, Mansour MA, Ito S, Hamaguchi M, Senga T.

Tumour Biol. 2016 May;37(5):6999. No abstract available.

PMID:
26825978
27.

CAR T Cells Targeting Podoplanin Reduce Orthotopic Glioblastomas in Mouse Brains.

Shiina S, Ohno M, Ohka F, Kuramitsu S, Yamamichi A, Kato A, Motomura K, Tanahashi K, Yamamoto T, Watanabe R, Ito I, Senga T, Hamaguchi M, Wakabayashi T, Kaneko MK, Kato Y, Chandramohan V, Bigner DD, Natsume A.

Cancer Immunol Res. 2016 Mar;4(3):259-68. doi: 10.1158/2326-6066.CIR-15-0060. Epub 2016 Jan 28.

28.

SATB1 and SATB2 play opposing roles in c-Myc expression and progression of colorectal cancer.

Mansour MA, Hyodo T, Akter KA, Kokuryo T, Uehara K, Nagino M, Senga T.

Oncotarget. 2016 Jan 26;7(4):4993-5006. doi: 10.18632/oncotarget.6651.

29.

Treatment with near-infrared radiation promotes apoptosis in pancreatic cancer cells.

Obayashi T, Funasaka K, Ohno E, Miyahara R, Hirooka Y, Hamaguchi M, Goto H, Senga T.

Oncol Lett. 2015 Sep;10(3):1836-1840. Epub 2015 Jun 19.

30.

FAM98A is a novel substrate of PRMT1 required for tumor cell migration, invasion, and colony formation.

Akter KA, Mansour MA, Hyodo T, Ito S, Hamaguchi M, Senga T.

Tumour Biol. 2016 Apr;37(4):4531-9. doi: 10.1007/s13277-015-4310-5. Epub 2015 Oct 27. Erratum in: Tumour Biol. 2016 May;37(5):7001.

PMID:
26503212
31.

Lenalidomide enhances the function of chimeric antigen receptor T cells against the epidermal growth factor receptor variant III by enhancing immune synapses.

Kuramitsu S, Ohno M, Ohka F, Shiina S, Yamamichi A, Kato A, Tanahashi K, Motomura K, Kondo G, Kurimoto M, Senga T, Wakabayashi T, Natsume A.

Cancer Gene Ther. 2015 Oct;22(10):487-95. doi: 10.1038/cgt.2015.47. Epub 2015 Oct 9.

PMID:
26450624
32.

Arginine methylation of ubiquitin-associated protein 2-like is required for the accurate distribution of chromosomes.

Maeda M, Hasegawa H, Sugiyama M, Hyodo T, Ito S, Chen D, Asano E, Masuda A, Hasegawa Y, Hamaguchi M, Senga T.

FASEB J. 2016 Jan;30(1):312-23. doi: 10.1096/fj.14-268987. Epub 2015 Sep 17.

PMID:
26381755
33.

UBE2S is associated with malignant characteristics of breast cancer cells.

Ayesha AK, Hyodo T, Asano E, Sato N, Mansour MA, Ito S, Hamaguchi M, Senga T.

Tumour Biol. 2016 Jan;37(1):763-72. doi: 10.1007/s13277-015-3863-7. Epub 2015 Aug 6. Erratum in: Tumour Biol. 2016 May;37(5):6999.

PMID:
26245992
34.

Activation of Yes-Associated Protein in Low-Grade Meningiomas Is Regulated by Merlin, Cell Density, and Extracellular Matrix Stiffness.

Tanahashi K, Natsume A, Ohka F, Motomura K, Alim A, Tanaka I, Senga T, Harada I, Fukuyama R, Sumiyoshi N, Sekido Y, Wakabayashi T.

J Neuropathol Exp Neurol. 2015 Jul;74(7):704-9. doi: 10.1097/NEN.0000000000000211.

PMID:
26049897
35.

HOXB13 and ALX4 induce SLUG expression for the promotion of EMT and cell invasion in ovarian cancer cells.

Yuan H, Kajiyama H, Ito S, Chen D, Shibata K, Hamaguchi M, Kikkawa F, Senga T.

Oncotarget. 2015 May 30;6(15):13359-70.

36.

EML4 promotes the loading of NUDC to the spindle for mitotic progression.

Chen D, Ito S, Yuan H, Hyodo T, Kadomatsu K, Hamaguchi M, Senga T.

Cell Cycle. 2015;14(10):1529-39. doi: 10.1080/15384101.2015.1026514.

37.

YAP is essential for tissue tension to ensure vertebrate 3D body shape.

Porazinski S, Wang H, Asaoka Y, Behrndt M, Miyamoto T, Morita H, Hata S, Sasaki T, Krens SFG, Osada Y, Asaka S, Momoi A, Linton S, Miesfeld JB, Link BA, Senga T, Shimizu N, Nagase H, Matsuura S, Bagby S, Kondoh H, Nishina H, Heisenberg CP, Furutani-Seiki M.

Nature. 2015 May 14;521(7551):217-221. doi: 10.1038/nature14215. Epub 2015 Mar 16.

38.

SATB2 suppresses the progression of colorectal cancer cells via inactivation of MEK5/ERK5 signaling.

Mansour MA, Hyodo T, Ito S, Kurita K, Kokuryo T, Uehara K, Nagino M, Takahashi M, Hamaguchi M, Senga T.

FEBS J. 2015 Apr;282(8):1394-405. doi: 10.1111/febs.13227. Epub 2015 Feb 18.

39.

Plasma-activated medium suppresses choroidal neovascularization in mice: a new therapeutic concept for age-related macular degeneration.

Ye F, Kaneko H, Nagasaka Y, Ijima R, Nakamura K, Nagaya M, Takayama K, Kajiyama H, Senga T, Tanaka H, Mizuno M, Kikkawa F, Hori M, Terasaki H.

Sci Rep. 2015 Jan 9;5:7705. doi: 10.1038/srep07705.

40.

Special AT-rich sequence-binding protein 2 suppresses invadopodia formation in HCT116 cells via palladin inhibition.

Mansour MA, Asano E, Hyodo T, Akter KA, Takahashi M, Hamaguchi M, Senga T.

Exp Cell Res. 2015 Mar 1;332(1):78-88. doi: 10.1016/j.yexcr.2014.12.003. Epub 2014 Dec 15.

PMID:
25523619
41.

Paired related homeobox 1 is associated with the invasive properties of glioblastoma cells.

Sugiyama M, Hasegawa H, Ito S, Sugiyama K, Maeda M, Aoki K, Wakabayashi T, Hamaguchi M, Natsume A, Senga T.

Oncol Rep. 2015 Mar;33(3):1123-30. doi: 10.3892/or.2014.3681. Epub 2014 Dec 18.

PMID:
25522823
42.

SHCBP1 is required for midbody organization and cytokinesis completion.

Asano E, Hasegawa H, Hyodo T, Ito S, Maeda M, Chen D, Takahashi M, Hamaguchi M, Senga T.

Cell Cycle. 2014;13(17):2744-51. doi: 10.4161/15384101.2015.945840.

43.

Inhibition of SNW1 association with spliceosomal proteins promotes apoptosis in breast cancer cells.

Sato N, Maeda M, Sugiyama M, Ito S, Hyodo T, Masuda A, Tsunoda N, Kokuryo T, Hamaguchi M, Nagino M, Senga T.

Cancer Med. 2015 Feb;4(2):268-77. doi: 10.1002/cam4.366. Epub 2014 Dec 1.

44.

Silencing of STRN4 suppresses the malignant characteristics of cancer cells.

Wong M, Hyodo T, Asano E, Funasaka K, Miyahara R, Hirooka Y, Goto H, Hamaguchi M, Senga T.

Cancer Sci. 2014 Dec;105(12):1526-32. doi: 10.1111/cas.12541. Epub 2014 Oct 23.

45.

GPC3 expression in mouse ovarian cancer induces GPC3‑specific T cell-mediated immune response through M1 macrophages and suppresses tumor growth.

Luo C, Shibata K, Suzuki S, Kajiyama H, Senga T, Koya Y, Daimon M, Yamashita M, Kikkawa F.

Oncol Rep. 2014 Sep;32(3):913-21. doi: 10.3892/or.2014.3300. Epub 2014 Jul 2.

46.

Expression of the miR200 family of microRNAs in mesothelial cells suppresses the dissemination of ovarian cancer cells.

Sugiyama K, Kajiyama H, Shibata K, Yuan H, Kikkawa F, Senga T.

Mol Cancer Ther. 2014 Aug;13(8):2081-91. doi: 10.1158/1535-7163.MCT-14-0135. Epub 2014 Jun 13.

47.

PLAGL2 regulates actin cytoskeletal architecture and cell migration.

Sekiya R, Maeda M, Yuan H, Asano E, Hyodo T, Hasegawa H, Ito S, Shibata K, Hamaguchi M, Kikkawa F, Kajiyama H, Senga T.

Carcinogenesis. 2014 Sep;35(9):1993-2001. doi: 10.1093/carcin/bgu081. Epub 2014 Mar 27.

PMID:
24675530
48.

B7-H4 overexpression correlates with a poor prognosis for cervical cancer patients.

Liu W, Shibata K, Koya Y, Kajiyama H, Senga T, Yamashita M, Kikkawa F.

Mol Clin Oncol. 2014 Mar;2(2):219-225. Epub 2013 Dec 12.

49.

Quantitative metabolome analysis profiles activation of glutaminolysis in glioma with IDH1 mutation.

Ohka F, Ito M, Ranjit M, Senga T, Motomura A, Motomura K, Saito K, Kato K, Kato Y, Wakabayashi T, Soga T, Natsume A.

Tumour Biol. 2014 Jun;35(6):5911-20. doi: 10.1007/s13277-014-1784-5. Epub 2014 Mar 5.

PMID:
24590270
50.

Silencing of TBC1D15 promotes RhoA activation and membrane blebbing.

Takahara Y, Maeda M, Hasegawa H, Ito S, Hyodo T, Asano E, Takahashi M, Hamaguchi M, Senga T.

Mol Cell Biochem. 2014 Apr;389(1-2):9-16. doi: 10.1007/s11010-013-1921-2. Epub 2013 Dec 14.

PMID:
24337944

Supplemental Content

Support Center